SCHEMBL6173280

SCHEMBL6173280

CC(c1ccnc2ccc(N(C)C)cc12)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.42
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
IP6K1 Q92551 1/20 0.33
ALDH3A1 P30838 1/20 0.31
HRH4 Q9H3N8 2/20 0.31
ACVR1 Q04771 1/20 0.31
LMNA P02545 1/20 0.31
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6250336 0.88 IGF1R (0.43) IGF1RJAK2JAK1HRH4LMNA
SCHEMBL6173787 0.86 IGF1R (0.42) IGF1RLMNA
SCHEMBL6174189 0.83 IGF1R (0.42) IGF1RJAK2JAK1HRH4LMNA
SCHEMBL6172547 0.81 IGF1R (0.41) IGF1RJAK2JAK1LMNACNR1
SCHEMBL6174623 0.80 IGF1R (0.42) IGF1RJAK2JAK1IP6K1ALDH3A1
SCHEMBL6172371 0.79 IGF1R (0.45) IGF1RLMNA
SCHEMBL6175238 0.79 IGF1R (0.43) IGF1RLMNA
SCHEMBL6175589 0.79 IGF1R (0.38) IGF1RLMNA
SCHEMBL6173570 0.78 IGF1R (0.43) IGF1RLMNA
SCHEMBL6172919 0.78 IGF1R (0.43) IGF1RHRH4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed